| Literature DB >> 34003517 |
David A Alvarez1, Steven R Corsi2, Laura A De Cicco2, Daniel L Villeneuve3, Austin K Baldwin4.
Abstract
Waterborne contaminants were monitored in 69 tributaries of the Laurentian Great Lakes in 2010 and 2014 using semipermeable membrane devices (SPMDs) and polar organic chemical integrative samplers (POCIS). A risk-based screening approach was used to prioritize chemicals and chemical mixtures, identify sites at greatest risk for biological impacts, and identify potential hazards to monitor at those sites. Analyses included 185 chemicals (143 detected) including polycyclic aromatic hydrocarbons (PAHs), legacy and current-use pesticides, fire retardants, pharmaceuticals, and fragrances. Hazard quotients were calculated by dividing detected concentrations by biological effect concentrations reported in the ECOTOX Knowledgebase (toxicity quotients) or ToxCast database (exposure-activity ratios [EARs]). Mixture effects were estimated by summation of EAR values for chemicals that influence ToxCast assays with common gene targets. Nineteen chemicals-atrazine, N,N-diethyltoluamide, di(2-ethylhexyl)phthalate, dl-menthol, galaxolide, p-tert-octylphenol, 3 organochlorine pesticides, 3 PAHs, 4 pharmaceuticals, and 3 phosphate flame retardants-had toxicity quotients >0.1 or EARs for individual chemicals >10-3 at 10% or more of the sites monitored. An additional 4 chemicals (tributyl phosphate, triethyl citrate, benz[a]anthracene, and benzo[b]fluoranthene) were present in mixtures with EARs >10-3 . To evaluate potential apical effects and biological endpoints to monitor in exposed wildlife, in vitro bioactivity data were compared to adverse outcome pathway gene ontology information. Endpoints and effects associated with endocrine disruption, alterations in xenobiotic metabolism, and potentially neuronal development would be relevant to monitor at the priority sites. The EAR threshold exceedance for many chemical classes was correlated with urban land cover and wastewater effluent influence, whereas herbicides and fire retardants were also correlated to agricultural land cover. Environ Toxicol Chem 2021;40:2165-2182. Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC. Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.Entities:
Keywords: Complex mixtures; Contaminants of emerging concern; Great Lakes Restoration Initiative; Screening and prioritization; ToxCast
Mesh:
Substances:
Year: 2021 PMID: 34003517 PMCID: PMC8361951 DOI: 10.1002/etc.5118
Source DB: PubMed Journal: Environ Toxicol Chem ISSN: 0730-7268 Impact factor: 3.742
Figure 1Map of sample sites and associated land cover. Identification of site codes is presented in Figure 4 and in Supplemental Data, Table SI‐1. Map base layers derived from Department of Agriculture and Agri‐Food Canada 2020; Homer et al. 2015; Instituto Nacional de Estadística Geografia e Informática et al. 2006a, 2006b; Steeves and Nebert 1994; US Department of Agriculture–Natural Resources Conservation Service et al. 2009.
Figure 4Maximum exposure–activity ratios (EARs) by chemical class computed from passive sampler chemistry data from 69 Great Lakes tributary sites collected in 2010 and 2014 for chemicals included in the ToxCast database. An “X” in the embedded table indicates major land cover within the watersheds that were significantly correlated with exceedance of an EAR threshold of 10–3 for chemical classes. Chemical classes not represented in the table did not have significant correlations. “Map Name” shows reference locations included on the map in Figure 1; “# Chems” shows number of chemicals with computed EAR values.
Figure 2Chemicals with information from ToxCast and ECOTOX used in the present study from passive samplers deployed at 69 sites within 62 tributaries of the Great Lakes, in 2010 and 2014. Number of chemicals represented in each category is shown in parentheses. PAH = polycyclic aromatic hydrocarbon; WW = wastewater; OC = organochlorine; PBDE = polybrominated diphenyl ether; PCB = polychlorinated biphenyl.
Figure 3Concentrations and potential for biological effects of organic compounds analyzed in passive samplers deployed at 69 sites within 62 tributaries of the Great Lakes, in 2010 and 2014. (A) Exposure–activity ratios (EARs) using ToxCast activity concentration at cutoff for screening of potential pathway‐based bioactivity from detected chemicals. (B–D) Toxicity quotients computed using effect concentrations from the ECOTOX knowledgebase for effects commonly used in hazard assessment (B, group 1) and other effects (C, group 2) and (D) concentrations of monitored chemicals. Compounds are grouped by chemical class and ordered by largest to smallest median EAR. Boxplots represent only sites where chemicals were detected. Compounds that were not detected are not included. Sites, number of sampling locations with detections of each chemical. Boxes, 25th to 75th percentiles; dark line, median; whiskers, data within 1.5 × the interquartile range (IQR); circles, values outside 1.5 × the IQR; vertical dashed lines indicate EAR threshold value of 10–3 (A) or toxicity quotient of 10–1 (B,C). HHCB = 1,3,4,6,7,8‐hexahydro‐4,6,6,7,8,8‐hexamethylcyclopenta [g]‐2‐benzopyran; AHTN = 7‐acetyl‐1,1,3,4,4,6‐hexamethyltetrahydronaphthalene; PCB = polychlorinated biphenyl; DDT = dichlorodiphenyltrichloroethane; DDE = dichlorodiphenyldichloroethylene; DDD = dichlorodiphenyldichlorethane; PBDE = polybrominated diphenyl ether; OC = organochlorine; PAH = polycyclic aromatic hydrocarbon; WW = wastewater.
Chemicals detected in passive samplers from Great Lakes tributaries that were identified to have potential for ecological hazard by exposure–activity ratios from ToxCast endpoints as individual chemicals or as components of chemical mixtures or by toxicity quotients from ECOTOX endpoints as individual chemicals
| Number of sites exceeding | ||||||
|---|---|---|---|---|---|---|
| EAR or TQ threshold | ||||||
| Sites | ToxCast | ECOTOX | ||||
| Chemical use class | Chemical name | Monitored | Individual | Mixtures | Group 1 | Group 2 |
| Detergent metabolites | 69 | 11 | 7 | 2 | 1 | |
| Fire retardant | TBEP | 69 | 18 | 10 | 0 | 0 |
| Fire retardant | TCPP | 69 | 19 | 10 | 0 | 0 |
| Fire retardant | TDCPP | 69 | 19 | 10 | 1 | 1 |
| Fire retardant | Tributyl phosphate | 69 | 4 | 10 | 0 | 0 |
| Flavor/fragrance | Galaxolide (HHCB) | 69 | — | — | 1 | 34 |
| Food Additive/plasticizer | Triethyl citrate | 69 | 0 | 7 | — | — |
| Herbicide | Atrazine | 69 | 27 | 23 | 39 | 39 |
| Insecticide | DEET | 69 | 6 | 18 | 18 | 18 |
| OC pesticides | Chlorpyrifos | 69 | 0 | 0 | 24 | 24 |
| OC pesticides | Dieldrin | 69 | 0 | 0 | 15 | 0 |
| OC pesticides | 69 | 0 | 0 | 13 | 1 | |
| PAHs | Benz[ | 69 | 1 | 15 | 0 | — |
| PAHs | Benzo[ | 69 | 2 | 17 | 0 | 0 |
| PAHs | Benzo[ | 69 | 19 | 17 | 0 | — |
| PAHs | Indeno[1,2,3‐ | 69 | 16 | 15 | — | — |
| PAHs | Pyrene | 69 | 1 | 1 | 29 | 0 |
| Pharmaceuticals | Caffeine | 69 | 10 | 9 | 0 | 0 |
| Pharmaceuticals | Carbamazepine | 69 | 1 | 1 | 14 | 28 |
| Pharmaceuticals | Tramadol | 36 | — | — | 10 | 10 |
| Pharmaceuticals | Venlafaxine | 69 | — | — | 11 | 11 |
| Plasticizer | DEHP | 69 | 26 | 10 | 38 | 38 |
| WW | dl‐Menthol | 69 | 9 | 9 | 0 | — |
EAR = exposure–activity ratio; TQ = toxicity quotient; OC = organochlorine; PAH = polycyclic aromatic hydrocarbon; TBEP = tris(2‐butoxyethyl) phosphate; TCPP = tris(2‐chloroisopropyl)phosphate; TDCPP = tris(1,3‐dichloro‐2‐propyl)phosphate; HHCB = 1,3,4,6,7,8‐hexahydro‐4,6,6,7,8,8‐hexamethylcyclopenta [g]‐2‐benzopyran; DEET = N,N‐diethyltoluamide; DDE = dichlorodiphenyldichloroethylene; DEHP = di(2‐ethylhexyl)phthalate; WW = wastewater.
Adverse outcome pathways (AOPs) and functional gene annotations relevant to ToxCast assays associated with chemical mixtures and individual chemicals with exposure activity ratios >10–3 at 10% or more of monitored sitesa
| Gene: assay: chemical/mixture | AOPs: overview | Functional annotations | No. sites |
|---|---|---|---|
|
AR: dl‐Menthol | Five AOPs under development | [1: Oocyte meiosis, pathways in cancer, prostate cancer]; [2: prostate cancer, susceptibility to; androgen insensitivity; hypospadias 1, X‐linked; androgen insensitivity, partial, with or without breast cancer; spinal and bulbar muscular atrophy of Kennedy]; [3: | 9 |
|
AHR: Benz[ pyrene | Three OECD‐endorsed AOPs | [1: Response to xenobiotic stimulus]; [3: | 17 |
|
AHR: Benzo[ fluoranthene | Three OECD‐endorsed AOPs | [1: Response to xenobiotic stimulus]; [3: | 17 |
|
CYP1A2: | Two OECD‐endorsed AOPs | [1: Steroid hormone biosynthesis, caffeine metabolism, tryptophan metabolism, linoleic acid metabolism, retinol metabolism, metabolism of xenobiotics by cytochrome P450, drug metabolism by cytochrome P450, metabolic pathways, chemical carcinogenesis] | 11 |
|
CYP19A1: | One OECD‐endorsed AOP | [1: Steroid hormone biosynthesis, metabolic pathways, ovarian steroidogenesis]; [2: aromatase excess syndrome, aromatase deficiency] | 10 |
|
CYP2B6: | Not applicable | [1: Arachidonic acid metabolism, retinol metabolism, metabolism of xenobiotics by cytochrome P450, drug metabolism by cytochrome P450, metabolic pathways]; [2: efavirenz central nervous system toxicity, susceptibility to and poor metabolism of] | 10; 18 |
|
ESR1: TBEP, p‐tert‐octylphenol, triethyl citrate | Six AOPs under developmentc,
| [1: Estrogen signaling pathway, prolactin signaling pathway, thyroid hormone signaling pathway, endocrine and other factor–regulated calcium reabsorption, proteoglycans in cancer]; [2: breast cancer; migraine, susceptibility to; myocardial infarction, susceptibility to; estrogen resistance; atherosclerosis, susceptibility to; HDL response to hormone replacement, augmented]; [3: | 7 |
|
ESR1, ESR2: Atrazine | Not applicable | [1: Estrogen signaling pathway, prolactin signaling pathway, thyroid hormone signaling pathway, endocrine and other factor–regulated calcium reabsorption, proteoglycans in cancer]; [2: breast cancer; migraine, susceptibility to; myocardial infarction, susceptibility to; estrogen resistance; atherosclerosis, susceptibility to; HDL response to hormone replacement, augmented]; [3: | 16 |
|
TDCPP; Atrazine, DEHP, TBEP, TCPP TDCPP | One AOP | [3: | 7; 8 |
|
PDE4A: | Not applicable | [1: Purine metabolism, cAMP signaling pathway, morphine addiction]; [3: | 23 |
|
SOX1: | Not applicable | [3: | 9 |
|
TSPO: DEHP, TBEP, tributyl phosphate, TCPP, TDCPP | Not applicable | [1: Neuroactive ligand–receptor interaction, HTLV‐I infection]; [3: | 10 |
ToxCast assay name; AOP overview provides a listing of relevant AOPs from the AOP‐Wiki and an overview of associated apical outcomes; official gene symbol for gene target associated with ToxCast assays; functional gene annotations from DAVID 6.8.
Annotation sources [1: Kyoto Encyclopedia of Genes and Genomes pathways (Homo sapiens)]; [2: Online Mendelian Inheritance in Man Disease (Homo sapiens)]; [3: GO Biological Process for a representative fish species]. If not listed for a given annotation source, no annotations were available for that source.
aopwiki.org.
https://aopwiki.org/aops/21; https://aopwiki.org/aops/131; https://aopwiki.org/aops/150.
https://aopwiki.org/aops/41; https://aopwiki.org/aops/43; https://aopwiki.org/aops/57.
https://aopwiki.org/aops/131; https://aopwiki.org/aops/21.
https://aopwiki.org/aops/41.
https://aopwiki.org/aops/25.
https://aopwiki.org; https://aopwiki.org/aops/167; https://aopwiki.org/aops/146; https://aopwiki.org/aops/200; https://aopwiki.org/aops/29.
https://aopwiki.org/aops/60.
DEHP = di(2‐ethylhexyl)phthalate; DEET = N,N‐diethyltoluamide; TBEP = tris(2‐butoxyethyl) phosphate; TCPP = tris(2‐chloroisopropyl)phosphate; TDCPP = tris(1,3‐dichloro‐2‐propyl)phosphate; OECD = Organisation for Economic Co‐operation and Development; HTLV‐I human T‐cell lymphotropic virus type 1.